Resultats de la cerca - Jean‐Pierre Riveline
- Mostrar 1 - 20 resultats de 31
- Anar a la pàgina següent
-
1
-
2
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlle... per Thomas Haak, H. Hanaire, Ramzi Ajjan, Norbert Hermanns, Jean‐Pierre Riveline, Gerry Rayman
Publicat 2016Artigo -
3
-
4
-
5
The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes per Yves Reznik, Élisabeth Bonnemaison, Guy Fagherazzi, Éric Renard, H. Hanaire, Pauline Schaepelynck, M. Mihaileanu, Jean‐Pierre Riveline
Publicat 2024Carta -
6
Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring per Dorothee Deiss, Jan Bolinder, Jean-Pierre Riveline, Tadej Battelino, Emanuele Bosi, Nadia Tubiana‐Rufi, David Kerr, Moshe Phillip
Publicat 2006Artigo -
7
Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study per Ronan Roussel, Jean‐Pierre Riveline, Éric Vicaut, Gérard de Pouvourville, B. Detournay, Corinne Emery, Fleur Levrat‐Guillen, Bruno Guerci
Publicat 2021Artigo -
8
Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes per Louis Potier, Boris Hansel, Étienne Larger, Jean‐François Gautier, Daphné Carreira, Rachel Assemien, Olivier Lantieri, Jean‐Pierre Riveline, Ronan Roussel
Publicat 2020Artigo -
9
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial per Ildiko Lingvay, Malik Benamar, Liming Chen, Ariel Fu, Esteban Jódar, Tomoyuki Nishida, Jean‐Pierre Riveline, Daisuke Yabe, Thomas Züger, Rosângela Réa
Publicat 2025Artigo -
10
Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial per Ildiko Lingvay, Malik Benamar, Liming Chen, Ariel Fu, Esteban Jódar, Tomoyuki Nishida, Jean‐Pierre Riveline, Daisuke Yabe, Thomas Züger, Rosângela Réa
Publicat 2025Errata/Corrigenda -
11
Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system per Jean‐Pierre Riveline, J. Teynié, S. Belmouaz, Sylvia Franc, Dured Dardari, Marc Bauwens, Valérie Caudwell, Stéphanie Ragot, Frank Bridoux, G. Charpentier, R. Maréchaud, Samy Hadjadj
Publicat 2009Artigo -
12
Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin per Franck Mauvais‐Jarvis, Eugène Sobngwi, Raphaël Porcher, Jean‐Pierre Riveline, Jean-Philippe Kévorkian, Christian Vaisse, G. Charpentier, Pierre-Jean Guillausseau, Patrick Vexiau, Jean‐François Gautier
Publicat 2004Artigo -
13
High Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency without Gene Mutation Suggests a Novel Genetic Mechanism Predisposing to Ketosis-Prone Diabetes per Eugène Sobngwi, Jean‐François Gautier, Jean-Philippe Kévorkian, Jean‐Marie Villette, Jean‐Pierre Riveline, Sumei Zhang, Patrick Vexiau, Suzanne M. Leal, Christian Vaisse, Franck Mauvais‐Jarvis
Publicat 2005Artigo -
14
Fetal Exposure to Maternal Type 1 Diabetes Is Associated With Renal Dysfunction at Adult Age per Charbel Abi Khalil, F. Travert, S. Fetita, François Rouzet, Raphaël Porcher, Jean‐Pierre Riveline, Samy Hadjadj, Étienne Larger, Ronan Roussel, Patrick Vexiau, Dominique Le Guludec, Jean‐François Gautier, Michel Marre
Publicat 2010Artigo -
15
A Rare Mutation in <i>ABCC8</i>/SUR1 Leading to Altered ATP-Sensitive K+ Channel Activity and β-Cell Glucose Sensing Is Associated With Type 2 Diabetes in Adults per Andrei I. Tarasov, Tamara Nicolson, Jean-Pierre Riveline, Tarvinder K. Taneja, Stephen A. Baldwin, Jocelyn M. Baldwin, G. Charpentier, Jean‐François Gautier, Philippe Froguel, Martine Vaxillaire, Guy A. Rutter
Publicat 2008Artigo -
16
Prise de position de la Société Francophone du Diabète (SFD) sur la prise en charge médicamenteuse de l’hyperglycémie du patient diabétique de type 2 per Patrice Darmon, B. Bauduceau, L. Bordier, J. Bringer, G. Chabrier, B Charbonnel, B. Detournay, P. Fontaine, André Grimaldi, Pierre Gourdy, Bruno Guerci, A. Penfornis, Jean‐Pierre Riveline, André Scheen
Publicat 2017Artigo -
17
PAX4 gene variations predispose to ketosis-prone diabetes per Franck Mauvais-Jarvis, Stuart B. Smith, Cédric Le May, Suzanne M. Leal, Jean‐François Gautier, Mariam Molokhia, Jean‐Pierre Riveline, Arun S. Rajan, Jean-Philippe Kévorkian, Sumei Zhang, Patrick Vexiau, Michael S. German, Christian Vaisse
Publicat 2004Artigo -
18
Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe <scp>COVID</scp> ‐19 in type 2 diabetes per Fawaz Alzaïd, Jean‐Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, Bénédicte Gaborit, Philippe Manivet, Stéphane Germain, Tiphaine Vidal-Trécan, Ronan Roussel, Jean‐Pierre Riveline, Élise Dalmas, Nicolas Venteclef, Jean‐François Gautier
Publicat 2020Artigo -
19
Polymorphisms in Type II SH2 Domain–Containing Inositol 5-Phosphatase (<i>INPPL1</i>, SHIP2) Are Associated With Physiological Abnormalities of the Metabolic Syndrome per Pamela J. Kaisaki, Marc Délepine, Peng Yeong Woon, Liam Sebag‐Montefiore, Steven P. Wilder, Stephan Menzel, Nathalie Vionnet, Evelyne Marion, Jean‐Pierre Riveline, G. Charpentier, Stéphane Schurmans, J Levý, Mark Lathrop, Martin Farrall, Dominique Gauguier
Publicat 2004Artigo -
20
Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages per Félix Renaudin, Lucie Orliaguet, Florence Castelli, François Fenaille, Aurélie Prignon, Fawaz Alzaïd, Christèle Combes, Aurélie Delvaux, Yasmina Adimy, Martine Cohen‐Solal, Pascal Richette, Thomas Bardin, Jean‐Pierre Riveline, Nicolas Venteclef, Frédéric Lioté, L. Campillo-Gimenez, Hang‐Korng Ea
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Medicine
Endocrinology
Internal medicine
Diabetes mellitus
Type 2 diabetes
Type 1 diabetes
Biology
Insulin
Genetics
Continuous glucose monitoring
Gene
Intensive care medicine
Disease
Glycemic
Blood Glucose Self-Monitoring
Hypoglycemia
Chemistry
Clinical trial
Coronavirus disease 2019 (COVID-19)
Diabetes management
Environmental health
Gastroenterology
Genotype
HNF1A
Infectious disease (medical specialty)
Liraglutide
Mutation
Pediatrics
Population
Randomized controlled trial